The cost of the EpiPen, a potentially lifesaving quick treatment for allergic reactions, has been rising steadily for nearly a decade — but it turned into a political scandal only this month, as Washington rushed to blast the manufacturer as a heartless price-gouger.
Mylan Pharmaceuticals bowed to pressure Thursday, saying ...